QTERN Launch

Qtern is used to treat adults with type 2 diabetes to improve control of their blood glucose (sugar) levels. It contains the active substances saxagliptin and dapagliflozin.

QTERN Launch

KEEP HEALTHY WITH QTERN

We came up with a concept that could be utilized for various sporting activities. The idea was to shine a light on the multiple challenges faced by a person with type 2 diabetes.

QTERN Launch

AstraZeneca is a renowned global, science-led biopharmaceutical business and their innovative medicines are used by millions of patients worldwide. SKEPPER was approached to create a launch campaign for QTERN and come up with a unique concept. QTERN is used to treat adults.


After a couple of brainstorming sessions, we came up with a concept that could be utilized for various sporting activities. The idea was to shine a light on the multiple challenges faced by a person with type 2 diabetes. The challenges were shown using various waves indicating fear of uncontrolled sugar, risk of hypoglycemia, pill burden, and the increasing cost of treatment. We portrayed QTERN as the aura around the patient and helps to sail easily through the waves. In short, QTERN is the answer to all your challenges and the medication helps one sail life easily.


Our options were chosen and AstreZeneca was content and appreciative of the outputs we presented.


Other Casestudies